Sunshine Biopharma SG&A Expense (Quarterly) Analysis

Sunshine Biopharma Inc (SBFM)

1.76 -1.56 (-46.99%) USD | NASDAQ | Apr 19, 16:00

1.60 -0.16 (-9.09%) After-Hours: 17:30

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2007. Upgrade now.

Date	Value
December 31, 2023	2.820M
September 30, 2023	2.442M
June 30, 2023	2.442M
March 31, 2023	3.126M
December 31, 2022	6.412M
September 30, 2022	1.422M
June 30, 2022	0.7232M
March 31, 2022	0.9214M
December 31, 2021	0.2091M
September 30, 2021	0.3015M
June 30, 2021	0.228M
March 31, 2021	1.127M
December 31, 2020	0.3556M
September 30, 2020	0.0746M
June 30, 2020	0.1351M
March 31, 2020	0.0414M
December 31, 2019	0.2535M
September 30, 2019	0.186M
June 30, 2019	0.0644M
March 31, 2019	0.1189M
December 31, 2018	0.1269M
September 30, 2018	0.2856M
June 30, 2018	0.5768M
March 31, 2018	0.1564M
December 31, 2017	0.1604M

Date	Value
September 30, 2017	0.11M
June 30, 2017	0.4717M
March 31, 2017	0.1085M
December 31, 2016	0.3205M
September 30, 2016	0.1011M
June 30, 2016	0.4236M
March 31, 2016	0.0544M
December 31, 2015	0.17M
September 30, 2015	0.1044M
June 30, 2015	0.3699M
March 31, 2015	0.1248M
December 31, 2014	0.3023M
September 30, 2014	0.2774M
June 30, 2014	0.4425M
March 31, 2014	0.3099M
December 31, 2013	0.5714M
September 30, 2013	0.1777M
June 30, 2013	0.1526M
March 31, 2013	0.8995M
December 31, 2012	0.1883M
September 30, 2012	0.3764M
June 30, 2012	0.1009M
March 31, 2012	0.0393M
December 31, 2011	0.2471M
September 30, 2011	0.1164M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.0414M

Minimum

Mar 2020

6.412M

Maximum

Dec 2022

1.226M

Average

0.3556M

Median

Dec 2020

SG&A Expense (Quarterly) Benchmarks